HIV, Vaginal Sex and PrEP Initiation: What Should You Tell Your Patients or Clients? (thebody.com)

This year, pre-exposure prophylaxis (PrEP) advocates noted a stunning disconnect between key organizations that issue guidelines on the use of tenofovir/emtricitabine (TDF/FTC, Truvada) for HIV prevention: The United States Centers for Disease Control and Prevention (CDC) continues to say that people need 20 days of daily TDF/FTC before they can consider themselves protected from vaginal … Continue reading HIV, Vaginal Sex and PrEP Initiation: What Should You Tell Your Patients or Clients? (thebody.com)

Advertisements

video from the Women’s PrEP Network meeting

we livestreamed the meeting. The internet connection wasn't perfect, but we got most of it. This is why it's in so many parts. Part 1 | Part 2 | Part 3  |  Part 4  | Part 5